BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA AND Diagnosis
31 results:

  • 1. Safety and efficacy of single insertion accelerated MR-image guided brachytherapy following chemo-radiation in locally advanced cervix cancer: modifying our EMBRACE during the COVID pandemic.
    Stevens MJ; Ko F; Martland J; Brown R; Bell L; Atyeo J; Yim J
    Radiat Oncol; 2023 Mar; 18(1):54. PubMed ID: 36941643
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Developing a predictive nomogram for colposcopists: a retrospective, multicenter study of cervical precancer identification in China.
    Xue P; Seery S; Wang S; Jiang Y; Qiao Y
    BMC Cancer; 2023 Feb; 23(1):163. PubMed ID: 36803785
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Impact of racial disparities on potential years of life lost due to gynecologic cancer in the United States: Trends from 1975 to 2017 based on SEER database.
    Kaur A; Wang S; Kumar A
    Gynecol Oncol; 2023 Mar; 170():266-272. PubMed ID: 36738485
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A study of modifiable factors associated with health-related quality of life in long-term cervical cancer survivors.
    Dahl AA; Bentzen AG; Fosså SD; Hess SL; Kiserud CE
    Acta Obstet Gynecol Scand; 2023 Feb; 102(2):218-225. PubMed ID: 36683549
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Treatment strategies in patients with gynecological sarcoma: Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA-NOGGO RU1).
    Roser E; Harter P; Zocholl D; Denschlag D; Chekerov R; Wimberger P; Kurzeder C; Hasenburg A; Muallem MZ; Mustea A; Emons G; Zeimet AG; Beck F; Arndt T; Brucker SY; Kommoss S; Heitz F; Welz J; Egger EK; Kalder M; Buderath P; Klar M; Marth C; Ulrich UA; Weigel M; Traub L; Anthuber C; Strauss H; Hanker L; Link T; Kubiak K; Melekian B; Hornung D; Pölcher M; Lampe B; Krauß T; Keilholz U; Flörcken A; Pietzner K; Sehouli J
    Int J Gynecol Cancer; 2023 Feb; 33(2):223-230. PubMed ID: 36631151
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A novel nomogram for predicting cancer-specific survival in women with uterine sarcoma: a large population-based study.
    Li YJ; Lyu J; Li C; He HR; Wang JF; Wang YL; Fang J; Ji J
    BMC Womens Health; 2022 May; 22(1):175. PubMed ID: 35568940
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Driver gene mutations in micro-invasive cervical squamous cancers have no prognostic significance.
    Kashofer K; Regauer S; Reich O; Petru E; Winter E
    Gynecol Oncol; 2022 Apr; 165(1):121-128. PubMed ID: 35101299
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. atm immunohistochemistry as a potential marker for the differential diagnosis of no specific molecular profile subtype and POLE-mutation subtype endometrioid carcinoma.
    Kitazono I; Kobayashi Y; Akahane T; Yamaguchi T; Yanazume S; Nohara S; Sakamoto I; Tabata K; Tasaki T; Kobayashi H; Tanimoto A
    Pathol Res Pract; 2022 Feb; 230():153743. PubMed ID: 34954471
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The mutational repertoire of uterine sarcomas and carcinosarcomas in a Brazilian cohort: A preliminary study.
    da Costa LT; Dos Anjos LG; Kagohara LT; Torrezan GT; De Paula CAA; Baracat EC; Carraro DM; Carvalho KC
    Clinics (Sao Paulo); 2021; 76():e2324. PubMed ID: 33503190
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
    Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Efficient mutation screening for cervical cancers from circulating tumor DNA in blood.
    Lee SY; Chae DK; Lee SH; Lim Y; An J; Chae CH; Kim BC; Bhak J; Bolser D; Cho DH
    BMC Cancer; 2020 Jul; 20(1):694. PubMed ID: 32718341
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Incidence and risk factors for lower limb lymphedema associated with endometrial cancer: Results from a prospective, longitudinal cohort study.
    Pigott A; Obermair A; Janda M; Vagenas D; Ward LC; Reul-Hirche H; Hayes SC
    Gynecol Oncol; 2020 Aug; 158(2):375-381. PubMed ID: 32499070
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Wait-time for hysterectomy and survival of women with early-stage cervical cancer: A clinical implication during the coronavirus pandemic.
    Matsuo K; Novatt H; Matsuzaki S; Hom MS; Castaneda AV; Licon E; Nusbaum DJ; Roman LD
    Gynecol Oncol; 2020 Jul; 158(1):37-43. PubMed ID: 32425268
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Adolescent characteristics and incidence of pre-malignant disease and invasive tumors of the cervix.
    Keinan Boker L; Twig G; Klaitman-Meir V; Derazne E; Shina A; Levine H; Kark JD
    Int J Gynecol Cancer; 2020 Jul; 30(7):959-968. PubMed ID: 32169875
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genomic Characterization of HPV-related and Gastric-type Endocervical Adenocarcinoma: Correlation With Subtype and Clinical Behavior.
    Hodgson A; Howitt BE; Park KJ; Lindeman N; Nucci MR; Parra-Herran C
    Int J Gynecol Pathol; 2020 Nov; 39(6):578-586. PubMed ID: 31855952
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Genome-wide association and epidemiological analyses reveal common genetic origins between uterine leiomyomata and endometriosis.
    Gallagher CS; Mäkinen N; Harris HR; Rahmioglu N; Uimari O; Cook JP; Shigesi N; Ferreira T; Velez-Edwards DR; Edwards TL; Mortlock S; Ruhioglu Z; Day F; Becker CM; Karhunen V; Martikainen H; Järvelin MR; Cantor RM; Ridker PM; Terry KL; Buring JE; Gordon SD; Medland SE; Montgomery GW; Nyholt DR; Hinds DA; Tung JY; ; Perry JRB; Lind PA; Painter JN; Martin NG; Morris AP; Chasman DI; Missmer SA; Zondervan KT; Morton CC
    Nat Commun; 2019 Oct; 10(1):4857. PubMed ID: 31649266
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping.
    Hernández-López R; Lorincz AT; Torres-Ibarra L; Reuter C; Scibior-Bentkowska D; Warman R; Nedjai B; Mendiola-Pastrana I; León-Maldonado L; Rivera-Paredez B; Ramírez-Palacios P; Lazcano-Ponce E; Cuzick J; Salmerón J;
    Clin Epigenetics; 2019 Oct; 11(1):140. PubMed ID: 31606044
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinical significance of serum adiponectin and visfatin levels in endometrial cancer.
    Wang Z; Gao S; Sun C; Li J; Gao W; Yu L
    Int J Gynaecol Obstet; 2019 Apr; 145(1):34-39. PubMed ID: 30702161
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Next-generation Sequencing of an Ovarian Spindle Cell Tumor Identified an Ovarian Low-grade Endometrial Stromal Sarcoma: A Rare Entity.
    Choi YJ; Ho J; Yoo J; Liu J; Lee A; Park JS; Hur SY
    Int J Gynecol Pathol; 2019 Sep; 38(5):474-478. PubMed ID: 30028354
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Impact of pelvic magnetic resonance imaging findings in the indication of uterine artery embolization in the treatment of myoma.
    Brito Pires NM; Godoi ET; Oliveira DC; Brandão SC; Abath CC; Pires P; Araujo Júnior E
    Ginekol Pol; 2017; 88(3):129-133. PubMed ID: 28397200
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.